Company Information

Intra-Cellular Therapies, Inc. (ITCI)

Overview Products Trials

Market Cap	$8.81B
Revenue TTM
Earnings Date	2025-02-20
Website

Upcoming PDUFA Dates

No upcoming PDUFAs found

Upcoming Trial Readouts

Feature coming soon

Upcoming Patent Expirations

Brand Name	Patent Number	Expire Date
CAPLYTA	10464938	3/12/2028
CAPLYTA	RE48825	2/12/2029
CAPLYTA	9199995	3/12/2029
CAPLYTA	9586960	3/12/2029
CAPLYTA	RE48825	3/12/2029
CAPLYTA	10117867	5/27/2029
CAPLYTA	9168258	5/27/2029
CAPLYTA	9616061	5/27/2029
CAPLYTA	8648077	12/1/2029
CAPLYTA	8598119	12/28/2029
CAPLYTA	RE48839	8/19/2033
CAPLYTA	10960009	12/3/2034
CAPLYTA	11026951	12/3/2034
CAPLYTA	9956227	12/3/2034
CAPLYTA	10695345	8/30/2039
CAPLYTA	11052084	8/30/2039
CAPLYTA	11690842	8/30/2039
CAPLYTA	11806348	8/30/2039
CAPLYTA	12070459	8/30/2039
CAPLYTA	12128043	8/30/2039
CAPLYTA	11980617	10/27/2039
CAPLYTA	12090155	7/7/2040
CAPLYTA	11753419	12/10/2040
CAPLYTA	12122792	12/10/2040